ArticleMolecules (Basel, Switzerland)2022

Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System.

Graham J Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.